2 completed. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow lortalamine: new trials by email Literature Review of lortalamine trials Research Report on lortalamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer 99mTc-MIP-1404 Injection, Whole-Body Planar and pelvic SPECT/CT scan - Prostate Cancer | Phase 3 | Completed | Molecular Insight Pharmaceuticals, Inc. | 531 | 2015-12-01 | 2019-04-10 |
| Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors I-131-CLR1404 - Solid Tumors | Phase 1 | Completed | Cellectar, Inc | 9 | 2009-06-01 | 2010-05-04 |
Disease (1) · Neoplasms (1) · Prostatic Neoplasms (1) · Recurrence (1)
Cellectar, Inc (1) · Molecular Insight Pharmaceuticals, Inc. (1)
United States (2) · Canada (1)